ALK+ Lung Cancer
There are two types of lung cancer:
ALK+ lung cancer is caused by a genetic mutation:
Why did I get ALK+ lung cancer:
ALK+ lung cancer is caused by a random genetic change. It is not because of something you did or something that was passed down to you by a family member. You also cannot pass it down to your children.
50% of ALK+ cancer patients are diagnosed before the age of 50, some in their teens or 20's
Unlike small cell lung cancer, ALK+ lung cancer also affects those who have never smoked
ALK+ lung cancer tends to be more common in people of East Asian ethnicity, and in women.
Treatment options:
-
ALK inhibitors are oral medicines (pills you swallow) that block the abnormal ALK-fusion proteins from sending signals that turn cells cancerous. Most ALK+ lung cancers respond best to this treatment.
Types of ALK Inhibitors:
Lorlatinib (3rd generation)- particularly effective at treating brain metastases
Alectinib (2nd generation)
Brigatinib (2nd generation)
Crizotinib (1st generation)
At some point during treatment, the cancer may start to grow again: this may require surgery, radiation, chemotherapy, or a change to another ALK inhibitor.
-
Chemotherapy utilizes drugs that kill fast-growing cells, including cancer cells. Because chemotherapy affects more than just the cancer cells, there are more side effects including hair loss, nausea, fatigue, and low blood counts.
-
In some cases, surgery can be used to remove lung tumors and nearby lymph nodes. This is most useful in early stages when the cancer hasn’t spread. Surgery is often used in combination with other treatments.
-
Uses high energy beams to destroy cancer cells in specific areas. This type of treatment is effective for specific areas, such as brain metastases, but does not treat cancer throughout the whole body.